Philadelphia, PA
Neurofeedback Therapy clinics in Philadelphia
Philadelphia has multiple clinics offering neurofeedback therapy, a form of EEG based biofeedback that trains the brain using real time electrical activity feedback. Neurofeedback is FDA cleared for relaxation and stress management, and many Philadelphia providers also market it for ADHD, anxiety, PTSD, sleep, concussion recovery, and peak performance. Those secondary claims sit beyond the FDA cleared indications and are considered off label, with Emerging evidence in ADHD and anxiety and weaker evidence elsewhere. Providers typically include licensed psychologists, LPCs, and mental health professionals, and the de facto quality standard is Board Certification in Neurofeedback (BCIA). A reputable Philadelphia clinic will start with a QEEG brain map to establish a baseline, set symptom based goals rather than vague optimization promises, and frame expectations realistically across a 20 session protocol. Pennsylvania does not license neurofeedback as a standalone profession, so scope depends on the provider's underlying credential. Cost and commitment vary widely, which makes careful vetting essential before signing up for a multi thousand dollar package.
Interventional Psychiatry
- Transcranial Magnetic Stimulation (TMS)
- Neurofeedback Therapy
- Ketamine Therapy
- Migraine Treatment
Regulatory context
A note on Pennsylvania's neurofeedback therapy rules.
Repetitive transcranial magnetic stimulation (rTMS) is regulated as a Class II prescription device. The first 510(k) clearance went to NeuroStar in 2008 for treatment-resistant major depressive disorder. Subsequent clearances expanded the on-label scope to obsessive-compulsive disorder (BrainsWay deep TMS, 2018), smoking cessation (BrainsWay, 2020), anxious depression as an adjunct indication (2021), and migraine via single-pulse TMS devices such as eNeura SpringTMS and SAVI Dual. Biofeedback instruments are cleared under 21 CFR 882.1425 as Class II devices for relaxation training and stress reduction. EEG-based neurofeedback systems hold 510(k) clearances in the same category. Cranial electrotherapy stimulation, tDCS wellness devices, and many vagus nerve stimulation accessories sold direct to consumers are not cleared as medical devices, and clinical claims beyond cleared indications are off-label.
-
Pennsylvania Medical Practice Act (63 P.S. 422.1 et seq.)
Defines the practice of medicine and supervision framework for delegated procedures including TMS technician work. -
Pennsylvania Professional Psychologists Practice Act (63 P.S. 1201 et seq.)
Governs licensed psychologists who deliver biofeedback and neurofeedback within scope.
The Pennsylvania State Board of Medicine and the Board of Osteopathic Medicine investigate TMS clinics for supervision lapses and off-label marketing. The Pennsylvania attorney general enforces the Unfair Trade Practices and Consumer Protection Law against deceptive medical device advertising, including neurofeedback cure claims. Wellness clinics offering CES or tDCS face scrutiny when marketing implies FDA-cleared medical treatment. Commercial insurers and Pennsylvania Medicaid typically require documented treatment-resistant depression before covering TMS for major depressive disorder.
Neurofeedback Therapy in Philadelphia, answered.
Explore related care